JW CreaGene is increasingly establishing its status as the leading company in the
new bio drugs
industry in the
What is dendritic cell therapeutics?
Dendritic cell therapeutics are customized to the patients by using the individual’s immune cells and is a new format of treatment technology that can be administered concurrently with other drugs since there is almost no side effect.View closer detail
Cytoplasmic Transduction Peptide (CTP) is a new drug delivery peptide for which JW CreaGene holds the patent right. It is an outstanding polymer delivery system with differentiated mobility characteristics within cytoplasm as well as high cell membrane penetration capability.View closer detail